Geolocation Technology, Inc. (FKSE:4018)

Market Cap	1.47B
Revenue (ttm)	682.00M
Net Income (ttm)	44.00M
Shares Out	1.56M
EPS (ttm)	28.19
PE Ratio	33.53
Forward PE	n/a
Dividend	10.00 (1.07%)
Ex-Dividend Date	Jun 27, 2025

Volume	1,300
Average Volume	1,555
Open	958.00
Previous Close	948.00
Day's Range	932.00 - 958.00
52-Week Range	850.00 - 1,288.00
Beta	-1.37
RSI	30.51
Earnings Date	Aug 12, 2025

About Checkpoint Therapeutics

Geolocation Technology, Inc. develops and provides web marketing and services. The company operates through two segments, IP Geolocation Business and IP Address Transfer business. It provides SURFPOINT, a service used on websites and applications for marketing and security purposes; Dokodoko JP; Easy log analysis, a tool to analyze web access; IP Plaza that displays prefecture names, area codes, and connection line information as search results; and Dokodoko ad, an internet advertising distribution service. The company also engages in the web p...

• Industry: Computer Programming, Data Processing, And Other Computer Related Services
• Founded: 2000
• Employees: 39
• Stock Exchange: Fukuoka Stock Exchange
• Ticker Symbol: 4018

Financial Performance

In 2024, Geolocation Technology's revenue was 716.00 million, a decrease of -6.65% compared to the previous year's 767.00 million. Earnings were 37.00 million, a change of 0.00%.